Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2013 (2013), Article ID 875791, 7 pages
http://dx.doi.org/10.1155/2013/875791
Review Article

HBV Perinatal Transmission

1Rawalpindi Medical College, Holy Family Hospital, 965-B, Saidpur Road, Satellite Town, Rawalpindi 46000, Pakistan
2Rawalpindi Medical College, Rawalpindi 46000, Pakistan
3Shifa International Hospital, Islamabad 44000, Pakistan
4Department of Medicine, Centre for Liver and Digestive Diseases, Holy Family Hospital, Rawalpindi 46000, Pakistan

Received 30 December 2012; Revised 30 March 2013; Accepted 1 April 2013

Academic Editor: Pierluigi Toniutto

Copyright © 2013 Muhammad Umar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Jonas, “Hepatitis B and pregnancy: an underestimated issue,” Liver International, vol. 29, no. 1, pp. 133–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Lavanchy, “Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures,” Journal of Viral Hepatitis, vol. 11, no. 2, pp. 97–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. Centers for Disease Control and Prevention (CDC), “Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data: United States,” Morbidity and Mortality Weekly Report, vol. 60, pp. 410–413, 2011. View at Google Scholar
  4. R. P. Beasley, C. Trepo, C. E. Stevens, and W. Szmuness, “The e antigen and vertical transmission of hepatitis B surface antigen,” American Journal of Epidemiology, vol. 105, no. 2, pp. 94–98, 1977. View at Google Scholar · View at Scopus
  5. B. J. McMahon, W. L. M. Alward, D. B. Hall et al., “Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state,” Journal of Infectious Diseases, vol. 151, no. 4, pp. 599–603, 1985. View at Google Scholar · View at Scopus
  6. W. J. Edmunds, G. F. Medley, D. J. Nokes, A. J. Hall, and H. C. Whittle, “The influence of age on the development of the hepatitis B carrier state,” Proceedings of the Royal Society B: Biological Sciences, vol. 253, no. 1337, pp. 197–201, 1993. View at Google Scholar · View at Scopus
  7. R. P. Beasley, L. Y. Hwang, G. C. Lee et al., “Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine,” The Lancet, vol. 2, no. 8359, pp. 1099–1102, 1983. View at Google Scholar · View at Scopus
  8. N. Leung, “Chronic hepatitis B in Asian women of childbearing age,” Hepatology International, vol. 3, supplement 1, pp. 24–31, 2009. View at Publisher · View at Google Scholar
  9. D. Z. Xu, Y. P. Yan, B. C. Choi et al., “Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study,” Journal of Medical Virology, vol. 67, no. 1, pp. 20–26, 2002. View at Publisher · View at Google Scholar
  10. Z. Wang, J. Zhang, H. Yang et al., “Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies,” Journal of Medical Virology, vol. 71, no. 3, pp. 360–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. N. A. Terrault and I. M. Jacobson, “Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy,” Seminars in Liver Disease, vol. 27, supplement 1, pp. 18–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Bai, L. Zhang, L. Ma, X. G. Dou, G. H. Feng, and G. Z. Zhao, “Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism,” World Journal of Gastroenterology, vol. 13, no. 26, pp. 3625–3630, 2007. View at Google Scholar · View at Scopus
  13. W. M. Xu, Y. T. Cui, L. Wang et al., “Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study,” Journal of Viral Hepatitis, vol. 16, no. 2, pp. 94–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Zhang, Y. F. Yue, G. Q. Bai, L. Shi, and H. Jiang, “Mechanism of intrauterine infection of hepatitis B virus,” The World Journal of Gastroenterology, vol. 10, pp. 437–438, 2004. View at Google Scholar
  15. D. Milich and T. J. Liang, “Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection,” Hepatology, vol. 38, no. 5, pp. 1075–1086, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Liu, Y. Dong, L. Zhang et al., “Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China,” Archives of Virology, vol. 154, no. 3, pp. 437–443, 2009. View at Publisher · View at Google Scholar
  17. R. Nie, L. Jin, H. Zhang, B. Xu, W. Chen, and G. Zhu, “Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization,” Fertility and Sterility, vol. 95, no. 5, pp. 1667–1671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. E. Singh, S. S. Plitt, C. Osiowy et al., “Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of canadian mothers and infants,” Journal of Viral Hepatitis, vol. 18, no. 7, pp. 468–473, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Inui, H. Komatsu, T. Sogo, T. Nagai, K. Abe, and T. Fujisawa, “Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus,” Journal of Medical Virology, vol. 79, no. 6, pp. 670–675, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Wang, G. Peng, M. Li et al., “Identification of hepatitis B virus vertical transmission from father to fetus by direct sequencing,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 34, no. 1, pp. 106–113, 2003. View at Google Scholar · View at Scopus
  21. V. C. Wong, A. K. Lee, and H. M. Ip, “Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant,” British Journal of Obstetrics and Gynaecology, vol. 87, no. 11, pp. 958–965, 1980. View at Publisher · View at Google Scholar
  22. K. Tse, S. L. Y. Siu, K. T. Yip et al., “Immuno-prophylaxis of babies borne to hepatitis B carrier mothers,” Hong Kong Medical Journal, vol. 12, no. 5, pp. 368–374, 2006. View at Google Scholar · View at Scopus
  23. R. P. Beasley, C. E. Stevens, I. S. Shiao, and H. C. Meng, “Evidence against breast feeding as a mechanism for vertical transmission of hepatitis B,” The Lancet, vol. 2, no. 7938, pp. 740–741, 1975. View at Google Scholar · View at Scopus
  24. Centers for Disease Control, “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on immunization practices. Part 1: childhood immunization,” Morbidity and Mortality Weekly Report, vol. 54, no. RR-16, pp. 1–32, 2005. View at Google Scholar
  25. S. A. Cowan, J. Bagdonaite, and K. Qureshi, “Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months,” Euro Surveillance, vol. 11, no. 6, article E060608.3, 2006. View at Google Scholar · View at Scopus
  26. M. M. Jonas, E. R. Schiff, M. J. O'Sullivan et al., “Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population,” Annals of Internal Medicine, vol. 107, no. 3, pp. 335–337, 1987. View at Google Scholar · View at Scopus
  27. J. Zuckerman, J. van Hattum, M. Cafferkey et al., “Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?” Lancet Infectious Diseases, vol. 7, no. 6, pp. 410–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. J. Lo, Y. T. Tsai, S. D. Lee et al., “Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers,” Journal of Infectious Diseases, vol. 152, no. 4, pp. 817–822, 1985. View at Google Scholar · View at Scopus
  29. M. Fortuin, J. Chotard, A. D. Jack et al., “Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation,” Lancet, vol. 341, no. 8853, pp. 1129–1131, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. P. I. Lee, C. Y. Lee, L. M. Huang, J. M. Chen, and M. H. Chang, “A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants,” Vaccine, vol. 13, no. 17, pp. 1685–1689, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. H. Ni, L. M. Huang, M. H. Chang et al., “Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies,” Gastroenterology, vol. 132, no. 4, pp. 1287–1293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. Hsu, D. S. Chen, C. H. Chuang et al., “Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers,” Journal of the American Medical Association, vol. 260, no. 15, pp. 2231–2235, 1988. View at Google Scholar · View at Scopus
  33. Y. M. Song, J. Sung, S. Yang, Y. H. Choe, Y. S. Chang, and W. S. Park, “Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus,” European Journal of Pediatrics, vol. 166, no. 8, pp. 813–818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Wiseman, M. A. Fraser, S. Holden et al., “Perinatal transmission of hepatitis B virus: an Australian experience,” Medical Journal of Australia, vol. 190, no. 9, pp. 489–492, 2009. View at Google Scholar · View at Scopus
  35. WHO, Report on the Expanded Program on Immunization (EPI), Department of Vaccines and Biologicals, WHO, Geneva, Switzerland, 2012, (Post-exposure immunization for hepatitis B), http://www.who.int/immunization/.
  36. G. R. Han, M. K. Cao, W. Zhao et al., “A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection,” Journal of Hepatology, vol. 55, no. 6, pp. 1215–1221, 2011. View at Publisher · View at Google Scholar
  37. J. S. Wang, H. Chen, and Q. R. Zhu, “Transformation of hepatits B serologic markers in babies born to hepatitis B surface antigen positive mothers,” World Journal of Gastroenterology, vol. 11, no. 23, pp. 3582–3585, 2005. View at Google Scholar · View at Scopus
  38. W. L. Zhang, J. Zhao, and W. Li, “Influencing factors of mother infant vertical transmission of hepatitis B virus,” Zhongguo Dang Dai Er Ke Za Zhi, vol. 13, no. 8, pp. 644–646, 2011. View at Google Scholar
  39. G. R. Han, C. L. Xu, W. Zhao, and Y. F. Yang, “Management of chronic hepatitis B in pregnancy,” World Journal of Gastroenterology, vol. 18, no. 33, pp. 4517–4521, 2012. View at Publisher · View at Google Scholar
  40. S. Sinha and M. Kumar, “Pregnancy and chronic hepatitis B virus infection,” Hepatology Research, vol. 40, no. 1, pp. 31–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Borgia, M. A. Carleo, G. B. Gaeta, and I. Gentile, “Hepatitis B in pregnancy,” World Journal of Gastroenterology, vol. 18, no. 34, pp. 4677–4683, 2012. View at Publisher · View at Google Scholar
  42. J. E. Hay, “Liver disease in pregnancy,” Hepatology, vol. 47, pp. 1067–1076, 2008. View at Publisher · View at Google Scholar
  43. E. B. Keeffe, D. T. Dieterich, S. H. B. Han et al., “A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update,” Clinical Gastroenterology and Hepatology, vol. 6, no. 12, pp. 1315–1341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. K. K. Lau, T. Piratvisuth, X. L. Kang et al., “Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B,” New England Journal of Medicine, vol. 352, no. 26, pp. 2682–2695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. T. T. Tran, “Management of hepatitis B in pregnancy: weighing the options,” Cleveland Clinic Journal of Medicine, vol. 76, supplement 3, pp. S25–S29, 2009. View at Publisher · View at Google Scholar
  46. N. H. Bzowej, “Hepatitis B therapy in pregnancy,” Current Hepatitis Reports, vol. 9, pp. 197–204, 2010. View at Publisher · View at Google Scholar
  47. W. Yi, M. Liu, and H. D. Cai, “Safety of lamivudine treatment for chronic hepatitis B in early pregnancy,” World Journal of Gastroenterology, vol. 18, no. 45, pp. 6645–6650, 2012. View at Publisher · View at Google Scholar
  48. L. Han, H. W. Zhang, J. X. Xie, Q. Zhang, H. Y. Wang, and G. W. Cao, “A meta-analysis of lamivudine for interruption of mother-to-child transmission hepatitis B virus,” World Journal of Gastroenterology, vol. 17, no. 38, pp. 4321–4333, 2011. View at Publisher · View at Google Scholar
  49. H. X. Jiang, G. R. Han, C. M. Wang, and Y. Ji, “Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B,” Zhonghua Gan Zang Bing Za Zhi, vol. 20, no. 12, pp. 888–891, 2012. View at Google Scholar
  50. C. L. Lai, E. Gane, Y. F. Liaw et al., “Telbivudine versus lamivudine in patients with chronic hepatitis B,” New England Journal of Medicine, vol. 357, no. 25, pp. 2576–2588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Deng, X. Zhou, S. Gao et al., “The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis,” Virology Journal, vol. 9, article 185, 2012. View at Google Scholar
  52. M. Liu, H. Cai, and W. Yi, “Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy,” Journal of Viral Hepatitis, supplement 1, pp. 65–70, 2013. View at Google Scholar
  53. J. Yang, X. M. Zeng, Y. L. Men, and L. S. Zhao, “Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus—a systematic review,” Virology Journal, vol. 5, article 100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Lee, Y. Gong, J. Brok, E. H. Boxall, and C. Gluud, “Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis,” British Medical Journal, vol. 332, no. 7537, pp. 328–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. F. E. Andre and A. J. Zuckerman, “Review: protective efficacy of hepatitis B vaccines in neonates,” Journal of Medical Virology, vol. 44, no. 2, pp. 144–151, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. N. A. Halsey, L. H. Moulton, J. C. O'Donovan et al., “Hepatitis B vaccine administered to children and adolescents at yearly intervals,” Pediatrics, vol. 103, no. 6, pp. 1243–1247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Coursaget, E. Relyveld, A. Brizard et al., “Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine,” Vaccine, vol. 10, no. 5, pp. 319–321, 1992. View at Google Scholar · View at Scopus
  58. Viral Hepatitis Prevention Board, “Viral hepatitis in infants and children: epidemiology and prevention:,” in Viral Hepatitis Prevention Board meeting, vol. 71, pp. 14–16, Viral Hepatitis, Lisbon, Portugal, April 1998.
  59. P. Grossheide and P. van Damme, Prevention and Control of Hepatitis B in the Community, Communication Diseases Series, 1996, edited by J. Hallauer, M. Kane, E. Mcloy, A. Meheus, and C. Roure.
  60. E. E. Mast, H. S. Margolis, A. E. Fiore et al., “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents,” Morbidity and Mortality Weekly Report, vol. 54, no. 16, pp. 1–31, 2005. View at Google Scholar · View at Scopus
  61. World Health Organization (WHO), “Hepatitis B vaccines. WHO position paper,” Weekly Epidemiol Record, vol. 28, pp. 255–263, 2004. View at Google Scholar
  62. D. B. Hipgrave, J. E. Maynard, and B. A. Biggs, “Improving birth dose coverage of hepatitis B vaccine,” Bulletin of the World Health Organization, vol. 84, no. 1, pp. 65–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. B. F. Otto, I. M. Suarnawa, T. Stewart et al., “At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain,” Vaccine, vol. 18, no. 5-6, pp. 498–502, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Rahman, A. Dahmen, S. Herzog-Hauff, W. O. Böcher, P. R. Galle, and H. E. Löhr, “Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen,” Hepatology, vol. 31, no. 2, pp. 521–527, 2000. View at Google Scholar · View at Scopus
  65. L. K. Pickering, Ed., Red Book: Report of the Committee on Infectious Diseases, American Academy of Pediatrics, Elk Grove Village, Ill, USA, 26th edition, 2003.
  66. C. C. Linnemann Jr. and S. Goldberg, “Letter: HBAg in breast milk,” The Lancet, vol. 2, no. 7873, p. 155, 1974. View at Google Scholar · View at Scopus
  67. E. H. Boxall, “Vertical transmission of hepatitis B,” Clinical & Experimental Obstetrics & Gynecology, vol. 10, pp. 41–48, 1983. View at Google Scholar
  68. H. H. Lin, H. Y. Hsu, M. H. Chang, P. J. Chen, and D. S. Chen, “Hepatitis B virus in the colostra of HBeAg-positive carrier mothers,” Journal of Pediatric Gastroenterology and Nutrition, vol. 17, no. 2, pp. 207–210, 1993. View at Google Scholar · View at Scopus
  69. D. Yang, Y. Li, and J. Song, “Significance of detection of HBV-DNA and CMV-DNA by polymerase chain reaction in screening mothers' milk,” Hunan Yike Daxue Xuebao, vol. 24, no. 1, pp. 44–46, 1999. View at Google Scholar · View at Scopus
  70. R. Y. M. Tseng, C. W. K. Lam, and J. Tam, “Breastfeeding babies of HBsAg-positive mothers,” The Lancet, vol. 2, no. 8618, p. 1032, 1988. View at Google Scholar · View at Scopus
  71. M. de Martino, C. Appendino, M. Resti, and M. E. Rossi, “Should hepatitis B surface antigen positive mothers breast feed?” Archives of Disease in Childhood, vol. 60, no. 10, pp. 972–974, 1985. View at Google Scholar · View at Scopus
  72. J. B. Hill, J. S. Sheffield, M. J. Kim, J. M. Alexander, B. Sercely, and G. D. Wendel, “Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers,” Obstetrics and Gynecology, vol. 99, no. 6, pp. 1049–1052, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. L. M. Gartner, J. Morton, R. A. Lawrence et al., “Breastfeeding and the use of human milk,” Pediatrics, vol. 115, pp. 496–506, 2005. View at Publisher · View at Google Scholar